Burrill & Company logo

Burrill & Company

North America, California, United States, San Francisco

Description

Burrill & Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.

Investor Profile

Burrill & Company has made 94 investments, with 0 in the past 12 months and 19% as lead.

Stage Focus

  • Series B (29%)
  • Series A (19%)
  • Series Unknown (17%)
  • Series C (13%)
  • Series D (10%)
  • Post Ipo Equity (5%)
  • Series E (2%)
  • Series F (1%)
  • Debt Financing (1%)
  • Private Equity (1%)

Country Focus

  • United States (96%)
  • United Arab Emirates (2%)
  • India (1%)
  • China (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Medical Device
  • Biopharma
  • Life Science
  • Therapeutics
  • Health Diagnostics
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Burrill & Company frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 4
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 6
Prolog Ventures
North America, Missouri, United States, St Louis
Co-Investments: 9
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 6
Biomark Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 4
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 6
GS
North America, California, United States, Mill Valley
Co-Investments: 7
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 6

Which angels does Burrill & Company often collaborate with?

AZ
North America, California, United States, Mountain View
Shared Deals: 1
JT
North America, Florida, United States, West Palm Beach
Shared Deals: 1

What are some of recent deals done by Burrill & Company?

Neos Therapeutics

Grand Prairie, Texas, United States

Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.

BiotechnologyLife ScienceMedicalTherapeutics
Series UnknownFeb 19, 2015
Amount Raised: $20,624,355
Nora Therapeutics

Palo Alto, California, United States

Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.

BiotechnologyHealth CareMedical Device
Series BApr 17, 2014
Amount Raised: $18,000,000
Neos Therapeutics

Grand Prairie, Texas, United States

Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.

BiotechnologyLife ScienceMedicalTherapeutics
Series CMar 4, 2014
Amount Raised: $15,500,000
BetterDoctor

San Francisco, California, United States

BetterDoctor, a technology company, delivers provider directory data and has a database that can be accessed through a responsive API.

AppsDatabaseDeveloper APIsHealth CareInternetMedicalMobileSearch Engine
SeedOct 22, 2013
Amount Raised: $2,600,000
NewBridge Pharmaceuticals

Dubai, Dubai, United Arab Emirates

Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.

BiotechnologyMedical DeviceOncologyPharmaceutical
Series CMay 29, 2013
Amount Raised: $48,000,000
Catalyst Biosciences

South San Francisco, California, United States

Catalyst Biosciences is a biopharmaceutical company that offers protease therapeutics to address disorders of the coagulation system.

BiopharmaBiotechnologyLife SciencePharmaceutical
Post Ipo EquityApr 1, 2013
Amount Raised: $5,072,000
Odyssey Thera

San Ramon, California, United States

Odyssey Thera develops cellular pharmacology strategy for the identification of medicines for cancer and other human diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownFeb 14, 2013
Amount Raised: $2,800,000
Strand Life Sciences

Bangalore, Karnataka, India

Strand is leading a new generation of healthcare defined by genetic insights into disease.

BioinformaticsBiotechnologyGeneticsHealth CareInformation TechnologyMedical
Series BFeb 14, 2013
MabVax Therapeutics

San Diego, California, United States

MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.

BiotechnologyMedicalPharmaceutical
Series BNov 20, 2012
Amount Raised: $5,250,000
Cobalt Technologies

Mountain View, California, United States

Cobalt Technologies develops technologies that focuses and designed for biofuels.

BiofuelBiotechnologyCleanTech
Series UnknownOct 1, 2012
Amount Raised: $4,977,000